BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8971156)

  • 1. Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.
    Shridhar R; Shridhar V; Rivard S; Siegfried JM; Pietraszkiewicz H; Ensley J; Pauley R; Grignon D; Sakr W; Miller OJ; Smith DI
    Cancer Res; 1996 Dec; 56(24):5576-8. PubMed ID: 8971156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas.
    Shridhar V; Rivard S; Shridhar R; Mullins C; Bostick L; Sakr W; Grignon D; Miller OJ; Smith DI
    Oncogene; 1996 May; 12(9):1931-9. PubMed ID: 8649854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal polymorphism in the incomplete trinucleotide repeat of the arginine-rich protein gene.
    Evron E; Cairns P; Halachmi N; Ahrendt SA; Reed AL; Sidransky D
    Cancer Res; 1997 Jul; 57(14):2888-9. PubMed ID: 9230196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.
    Shridhar V; Rivard S; Wang X; Shridhar R; Paisley C; Mullins C; Beirnat L; Dugan M; Sarkar F; Miller OJ; Vaitkevicius VK; Smith DI
    Oncogene; 1997 May; 14(18):2213-6. PubMed ID: 9174057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
    Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
    Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
    Zhang SY; Klein-Szanto AJ; Sauter ER; Shafarenko M; Mitsunaga S; Nobori T; Carson DA; Ridge JA; Goodrow TL
    Cancer Res; 1994 Oct; 54(19):5050-3. PubMed ID: 7923115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
    Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
    Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of ST7 gene alterations in human cancer.
    Dong SM; Sidransky D
    Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
    Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
    Kim SK; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman WN; Hong WK; Lotan R; Mao L
    Cancer Res; 1996 Jun; 56(11):2519-21. PubMed ID: 8653689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
    Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
    Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
    Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
    Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.